Ulixacaltamide

Name: Ulixacaltamide in Essential tremor: Deep brain stimulation
Published: 2026-09-14T15:39:06-04:00

Essential tremor

Manufacturer: Praxis Precision Medicines
Regulatory submission: NDA submitted by February 2026
Launch: Not announced
Last updated: September 19, 2026

Section

Product information and disease description Place of product in therapy Approaches to treatment Current treatment options and standard of care

Deep brain stimulation

1 evidence topic · 1 source

MDS recommendations for thalamic interventions

“Unilateral Ventralis intermedius thalamic DBS, radiofrequency thalamotomy, and MRI-guided focused ultrasound thalamotomy were considered possibly useful.” (opens the source at this quote in a new tab)